10,000 and Counting: Safe Pro Group’s Epic Mine Detections in Ukraine, Saving the World One Bite at a Time

Working in Ukraine with Leading Agricultural Producer to Restore War-Torn Farmland A Historic Milestone in Mine Detection and Land Reclamation It’s not every day that you hear about drones and Artificial Intelligence coming together to detect explosive devices in war-torn farmland, but that’s exactly what Safe Pro Group Inc. has achieved in Ukraine. With over…

Read More

Breaking: Ondas Holdings’ Airobotics Scores $1M Grant from Israel Innovation Authority to Boost AI-Powered Irone Drone Raider System

Breaking: Ondas Holdings’ Airobotics Scores $1M Grant from Israel Innovation Authority to Boost AI-Powered Iron Drone Raider System Funding accelerates development of new features for the Iron Drone Raider, an advanced drone interception system Need for effective defensive counter-drone solutions has never been greater In an exciting development, Ondas Holdings Inc. has secured a significant…

Read More

Revolutionizing Industries: 3D Systems Unveils Exciting New Products at Formnext 2024

Exciting Times in the World of 3D Printing Breaking News ROCK HILL, S.C., Nov. 07, 2024 (GLOBE NEWSWIRE) — Today, 3D Systems (NYSE:DDD) announced several new products it will showcase at Formnext 2024 including advanced printing technologies and materials engineered to help customers meet a variety of application needs and accelerate innovation. The company is…

Read More

Get Ready to Be Wowed: Sona Nanotech’s THT Cancer Therapy Takes the Stage at NCL’s 20th Anniversary Symposium (Plus, a Sneak Peek at What’s Next!)

Welcome to the Exciting World of Cancer Nanotechnology! Dr. Len Pagliaro Showcases Sona Nanotech’s Targeted Hyperthermia Therapy at NCL Symposium Halifax, Nova Scotia– November 7, 2024 – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) Hey there, fellow science enthusiasts! Have you heard the latest buzz in the world of cancer research? Sona Nanotech’s Chief Scientific…

Read More

Aptevo Therapeutics Releases 3Q 2024 Financial Results and Business Update

Aptevo Therapeutics Inc. Reports Clinical Milestones and Financial Results Business Highlights In the third quarter of 2024, Aptevo Therapeutics Inc. achieved significant milestones in its clinical programs. The company initiated the mipletamig Phase 1b/2 clinical trial, “RAINIER,” in frontline acute myeloid leukemia (AML) patients. This decision was informed by positive results from the dose escalation…

Read More

Breaking News: Modular Medical’s GLP-1 Proof of Concept Study Yields Exciting Results!

Exciting News in Weight Loss and Blood Glucose Control Modular Medical’s Groundbreaking Study Reveals Promising Results SAN DIEGO, CA / ACCESSWIRE / November 7, 2024 It’s not every day that we hear about groundbreaking studies that could potentially revolutionize the way we approach weight loss and blood glucose control. Modular Medical, Inc., a leading insulin…

Read More

Taking Flight: Wheels Up Soars with Impressive Third Quarter Results

Financial Performance Improvement Driven by Operational Initiatives at Wheels Up Experience Inc. ATLANTA , Nov. 7, 2024 /PRNewswire/ — Wheels Up Experience Inc. (NYSE:UP) today announced financial results for the third quarter, which ended September 30, 2024. Over the past year, Wheels Up Experience Inc. has seen a significant improvement in their financial performance, driven…

Read More